EPS Bio Technology Corp.

4183

TW0004183009

Medical Equipment, Supplies & Distribution

End-of-day quote Taipei Exchange Other stock markets 03:30:00 03/06/2024 am IST			5-day change	1st Jan Change
22.5 ^TWD	+0.90%		+0.45%	-14.93%

14/05	EPS Bio Technology Corp. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
08/05	EPS Bio Technology Corp. Approves Dividend for the Year 2023	CI

Board of Directors Approves Proposal to Distribute Dividends

May 06, 2021 at 10:10 am IST

EPS Bio Technology Corp. announced cash dividends of NTD 1.2 per share or NTD 28,560,000.

Latest news about EPS Bio Technology Corp.

EPS Bio Technology Corp. Reports Earnings Results for the First Quarter Ended March 31, 2024	14/05	CI
EPS Bio Technology Corp. Approves Dividend for the Year 2023	08/05	CI
EPS Bio Technology Corp. Reports Earnings Results for the Full Year Ended December 31, 2023	20/03	CI
EPS Bio Technology Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	09/11	CI
EPS Bio Technology Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	10/23/10	CI
EPS Bio Technology Corp. Appoints Lin, Chih-Heng as Research and Development Officer	09/23/09	CI
EPS Bio Technology Corp. Reports Earnings Results for the First Quarter Ended March 31, 2023	13/23/13	CI
EPS Bio Technology Corp. Approves Dividend for the Year 2022, Payable on August 7, 2023	04/23/04	CI
EPS Bio Technology Corp. Appoints Kuo,Po-Hsiung as Vice President and Financial Officer	04/23/04	CI
EPS Bio Technology Corp. Announces Executive Changes	31/23/31	CI
EPS Bio Technology Corp. Reports Earnings Results for the Full Year Ended December 31, 2022	28/23/28	CI
EPS Bio Technology Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	09/22/09	CI
EPS Bio Technology Corp. Announces Appointment of Members of Compensation Committee	04/22/04	CI
EPS Bio Technology Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	04/22/04	CI
Eps Bio Technology Corp. Approves Cash Dividend for the Year 2021, Payable on August 4, 2022	24/22/24	CI
EPS Bio Technology Corp. Proposes Cash Dividends for 2021	05/22/05	CI
EPS Bio Technology Corp. Reports Earnings Results for the First Quarter Ended March 31, 2022	05/22/05	CI
EPS Bio Technology Corp. Reports Earnings Results for the Full Year Ended December 31, 2021	23/22/23	CI
EPS Bio Technology Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	05/21/05	CI
Eps Bio Technology Corp. Reports Earnings Results for the Second Quarter Ended June 30, 2021	06/21/06	CI
EPS Bio Technology Corp. Approves Cash Dividend for the Year 2020, Payable on August 13, 2021	20/21/20	CI
Eps Bio Technology Corp. Reports Earnings Results for the First Quarter Ended March 31, 2021	07/21/07	CI
Board of Directors Approves Proposal to Distribute Dividends	06/21/06	CI
Eps Bio Technology Corp. Reports Earnings Results for the Full Year Ended December 31, 2020	17/21/17	CI
Eps Bio Technology Corp. Reports Earnings Results for the Third Quarter Ended September 30, 2020	04/20/04	CI

Chart EPS Bio Technology Corp.

Duration

Period

More charts

EPS Bio Technology Corp. is a Taiwan-based company principally engaged in the manufacture and sales of medical test strips and equipment. The Company's main products include blood glucose testers, blood glucose test strips and electric breast pumps. The Company distributes its products mainly to overseas markets, such as Europe, North America and the rest areas of Asia.

Sector

Medical Equipment, Supplies & Distribution

More about the company

Income Statement Evolution

More financial data

Sector Diagnostic & Testing Substances

	1st Jan change	Capi.
EPS BIO TECHNOLOGY CORP.	-14.93%	1.63Cr
BIOMÉRIEUX	-4.22%	1.24TCr
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.	-0.60%	821.51Cr
DIASORIN S.P.A.	+6.61%	571.74Cr
AUTOBIO DIAGNOSTICS CO., LTD.	-10.21%	411.13Cr
10X GENOMICS, INC.	-60.62%	268.39Cr
ANDON HEALTH CO., LTD.	+10.62%	267.87Cr
VITROLIFE AB	-5.50%	237.39Cr
MYRIAD GENETICS, INC.	+15.73%	206Cr
GUANGZHOU WONDFO BIOTECH CO.,LTD	-9.18%	180.32Cr